Share Based Compensation (Tables)

3 Months Ended

6 Months Ended

Jun. 30, 2022

Jun. 30, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The assumptions used to value SARs granted in 2021 are as follows:

	2021 grant with 7 year expiration		2021 grant with 5 year expiration
Risk-free interest rate	1.06	%	0.74	%
Expected dividend yield	3.00	%	3.00	%
Expected common stock volatility	55.59	%	55.59	%
Expected life	7 years		5.5 years

Share-based Payment Arrangement, Option, Activity

A summary of our SAR and stock option activity during the first six months of 2022 and 2021 is as follows:

	For the Six Months Ended June 30,
	2022
	Options/SARs	Aggregate Intrinsic Value (in thousands)		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	491,792				$	21.32
Granted	—				—
Exercised	(1,200)				12.01
Forfeited	—				—
Expired	—				—
Outstanding, June 30	490,592	$	—	6.45	$	21.34
Exercisable, June 30	244,057	$	1,858,572	4.59	$	20.16

	For the Six Months Ended June 30,
	2021
	Options/SARs	Aggregate Intrinsic Value (in thousands)		Remaining Contractual Term (Yrs.)	Weighted-Average Exercise Price
Outstanding, January 1	329,203				$	20.47
Granted	—				—
Exercised	(800)				12.01
Forfeited	—				—
Expired	—				—
Outstanding, June 30	328,403	$	1,103	5.85	$	20.49
Exercisable, June 30	218,216	$	1,103	5.18	$	18.53

Share-based Payment Arrangement, Restricted Stock Unit, Activity

	RSUs	Weighted Average Grant Date Fair Value
Nonvested, December 31, 2021	13,015	$	21.24
Granted	—	—
Forfeited	—	—
Vested	(5,246)	22.24
Nonvested, June 30, 2022	7,769	$	20.57

	RSUs	Weighted Average Grant Date Fair Value
Nonvested, December 31, 2020	15,686	$	20.40
Granted	—	—
Forfeited	—	—
Vested	(3,400)	19.61
Nonvested, June 30, 2021	12,286	$	20.62